Evidence map›Paper›PMID 42397581›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Personal pathways to success: an innovative program to overcome cancer patient barriers to tobacco cessation and promote patient participation.

Cary A Presant, Brenda Gascon, Sophia Yeung, Jonjon Macalintal, Argelia Sandoval, Dan Raz, Loretta Erhunmwunsee, Janet Cronkhite, Khristie Davy, Mary Cianfrocca and 3 more

Abstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cary A Presant *City of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA. cpresant@coh.org.ORCID http://orcid.org/0000-0002-4559-2826
Brenda GasconCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Sophia YeungCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Jonjon MacalintalCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Argelia SandovalCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Dan RazCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Loretta ErhunmwunseeCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Janet CronkhiteCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Khristie DavyCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Mary CianfroccaCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Ravi SalgiaCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Yuman FongCity of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.
Kimlin Tam Ashing *City of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA, 91010, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTobacco cessation is an important supportive component of cancer care. We developed a novel program to overcome cancer patient barriers to tobacco cessation and improve outcomes.

methodsThe personal pathways to success (PPS) program consisted of core components of a motivational interview, an instructional video on tobacco cessation, referral to cessation consultation, and/or an offer of cessation medications. Patients who agreed to participate in PPS were also offered the choice of 30 additional PPS supplemental support cessation services. Participants were active smokers before planned surgery at City of Hope (COH) and were referred to the PPS program. We compared tobacco use in patients who participated in PPS with supplemental support services to patients who did not participate. We compared non-Hispanic white patients to patients from minority groups. Evaluations of tobacco use were performed before surgery in all patients, and at 30 days, 3, 6, 9, and 12 months after surgery in PPS participants, and at 12 months in non-participants.

resultsAmong 70 patients, 7 were re-directed by insurance to a non-COH provider. Among the other 63 patients, 58 completed the motivational interview (acceptability rate 92%). Thirty-five of 63 patients (56%) agreed to participate in PPS with supplemental support services. There was equal use of services in non-Hispanic white patients and in patients from minoritized backgrounds. Abstinence preoperatively was 17% in participants and 6% in non-participants. At 12 months after surgery, 42% of participants were abstinent versus 17% of non-participants (p = 0.11). At 12 months after surgery, 55% of participants were abstinent from combustible tobacco use (abstinent or only vaping) compared to 22% of non-participants (p = 0.037).

conclusionsThe PPS program is feasible. Participation is associated with reduced cigarette use among cancer patients. Further studies are warranted. IMPLICATIONS: Allowing cancer patients to choose among a defined menu of supplemental cessation services offers a method to support patients in their goal of quitting.

Indexed as

NeoplasmsPatient ParticipationSmoking CessationTobacco Use CessationAdherence InterventionsAdultAgedFemaleHumansMaleMiddle AgedMotivational InterviewingReferral and ConsultationBarriers to tobacco cessationPatients from minority groupsPersonalizing tobacco cessationSmoking cessationTobacco cessation services

Identifiers

PMID42397581
PMCPMC13331915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.